Study identifies new molecular target for cancer therapy

Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have identified a new molecular drug target that could result in new cancer drugs with fewer side effects. Previous studies have shown that vascular endothelial growth factor-A (VEGF-A) ­- a potent […]

Continue Reading

Closed Baby Formula Plant May Reopen by Next Week

THURSDAY, May 19, 2022 — A baby formula plant closed in February at the heart of the current U.S. shortage of the product could reopen as soon as next week, U.S. Food and Drug Administration Commissioner Dr. Robert Califf told House lawmakers on Thursday. The Abbott Nutrition’s Michigan formula plant is the largest in the […]

Continue Reading

Two-Drug Inhaler Could Reduce Asthma Attacks

By Amy Norton HealthDay Reporter THURSDAY, May 19, 2022 — Two drugs are better than one when it comes to stopping asthma attacks in progress, a new clinical trial has found. The study, of more than 3,100 asthma patients, found that a two-drug “rescue” inhaler worked better than a standard inhaler in thwarting severe asthma […]

Continue Reading

Good News, Bad News on Black Americans and Cancer

By Alan Mozes HealthDay Reporter THURSDAY, May 19, 2022 — A new report on how Black Americans are faring against cancer offers up a decidedly mixed picture. The risk that a Black man or woman in America will die from cancer has steadily declined over the last two decades, the newly published research found. Unfortunately, […]

Continue Reading